What's Going On With Vanda Pharmaceuticals Shares Today?
What's Going On With Vanda Pharmaceuticals Shares Today?
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading lower after Future Pak withdrew its proposal to purchase the company.
萬達生物製藥股份有限公司（納斯達克:VNDA）股價下跌，因未來派克撤回了其購買公司的提議。
"Consistent with the position indicated in its June 13, 2024 letter to Vanda Pharmaceuticals, Future Pak LLC and its affiliates today announced that it is withdrawing its offer to acquire the company, effective immediately, and will focus on other strategic objectives," according to a statement.
根據一份聲明：“與其2024年6月13日寫給萬達生物製藥的回應中表明的立場一致，未來派克及其附屬公司今天宣佈立即撤回其購買公司的提議，並專注於其他戰略目標。”
This decision follows Vanda's ongoing lack of response and their rejection of Future Pak's final proposal.
這一決定是基於萬達一直未回應未來派克並拒絕其最終提議。
According to Benzinga Pro, VNDA stock has lost over 9% in the past year. Investors can gain exposure to the stock via Invesco NASDAQ Future Gen 200 ETF (NASDAQ:QQQS).
據Benzinga Pro報道，VNDA股票在過去一年中下跌了超過9%。投資者可以通過景順納斯達克未來200 ETF（納斯達克:QQQS）獲得股票曝光。
In a recent press release, Vanda mentioned that the takeover proposals from Future Pak and Cycle Group substantially undervalued the company.
在最近的新聞發佈中，萬達提到未來派克和賽科集團的收購提議大大低估了公司。
Vanda highlighted that the unsolicited proposal from Cycle Group for $8.00 per share and the revised unsolicited proposal from Future Pak to acquire Vanda for $8.50-$9.00 per share are not in the best interests of the company and its shareholders. "Accordingly, the Board has rejected the proposals," the company said then.
萬達強調，賽科集團以每股8.00美元的非約請性提議和未來派克修改後的提議以每股8.50-9.00美元的價格收購萬達股份並不符合公司及其股東的最佳利益。公司表示：“因此，董事會已經拒絕了這些提議。”
Earlier in April, Vanda rejected Future Pak's $7.25 – $7.75 per share offer, saying it significantly undervalued the company.
4月份早些時候，萬達拒絕了未來派克每股7.25-7.75美元的收購提議，稱其大大低估了公司。
In April, the FDA approved Vanda Pharmaceuticals' Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
今年4月，美國FDA批准了萬達製藥的Fanapt（iloperidone）片劑，用於治療成人雙相I型障礙相關的急性躁狂或混合發作。
Price Action: VNDA shares are trading lower by 1.92% to $5.865 at last check Thursday.
價格走勢：VNDA股價週四最後查詢下跌了1.92％至5.865美元。
Photo via Shutterstock
圖片來自shutterstock。
譯文內容由第三人軟體翻譯。